September 2024: Updated once weekly oral methotrexate SMS for patients within adult gastroenterology services

News

September 2024: Updated once weekly oral methotrexate SMS for patients within adult gastroenterology services


Methotrexate drug entry: 8.4.3 Antifolates

The updated guideline covers the use of methotrexate for the treatment of the following indications: Maintenance of remission of severe Crohn's disease (unlicensed) and reducing risks of immunogenicity alongside anti-TNF treatments in the management of inflammatory bowel disease (unlicensed).

See here for more recent updates to the formulary.